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Abstract.  We have examined the role of feedback- 
regulation in the expression of the nonmuscle actin 
genes. C2 mouse myoblasts were transfected with the 
human ~- and ~-actin genes. In ~-actin transfectants 
we found that the total actin mRNA and protein pools 
remained unchanged. Increasing levels of human T-actin 
expression resulted in a progressive down-regulation 
of mouse/~- and ~/-actin mRNAs. Transfection of the 
~-actin gene resulted in an increase in the total actin 
mRNA and protein pools and induced an increase in 
the levels of mouse/3-actin mRNA. In contrast, trans- 
fection of a/~-actin gene carrying a single-point mu- 
tation ~sm) produced a feedback-regulatory response 
similar to that of the 7-actin gene. Expression of a 
/~-actin gene encoding an unstable actin protein had no 
impact on the endogenous mouse actin genes. This sug- 
gests that the nature of the encoded actin protein deter- 
mines the feedback-regulatory response of the mouse 
genes. The role of the actin cytoskeleton in mediating 
this feedback-regulation was evaluated by disruption of 
the actin network with Cytochalasin D. We found that 
treatment with Cytochalasin D abolished the down- 
regulation of mouse ~,-actin in both the ~- and/3sm- 
actin transfectants. In contrast, a similar level of in- 
crease was observed for the mouse/3-actin mRNA in 
both control and transfected cells. These experiments 
suggest that the down-regulation of mouse 3,-actin 
mRNA is dependent on the organization of the actin 
cytoskeleton. In addition, the mechanism responsible 
for the down-regulation of B-actin may be distinct from 
that governing 7-actin. We conclude that actin feedback- 
regulation provides a biochemical assay for differences 
between the two nonmuscle actin genes. 
M 
AMMALIAN  nonmuscle cell cytoarchitecture is com- 
prised of three major polymeric structures:  mi- 
crotubules, microfilaments, and intermediate fila- 
ments. Regulation  of the synthesis  and assembly of these 
polymers  is likely  to have an important role in the deterwina- 
tion of  cell morphology. In particular, it is to be expected  that 
the regulation of cellular content of each of these polymers 
may contribute to the determination of cell size and shape. 
It is therefore important to determine  whether  the expression 
of structural protein genes is programmed to produce a fixed 
level of  mRNA output. Such a mechanism  could regulate  cell 
morphology via the control of structural protein monomer 
supply. Alternatively, it might be expected that the function 
of architectural components is monitored by the cell such 
that gene expression of a structural protein can be feedback- 
regulated to satisfy cellular demand. The term autoregula- 
tion can be used to describe a system where it has definitely 
been established that the gene product directly regulates its 
own expression, however, in all other cases, the phenomenon 
will be described as feedback-regulation. 
The discovery of tubulin autoregulation has demonstrated 
that the cell can regulate monomer supply of tubulin in ac- 
cord with cellular demand for microtubules (Ben-Ze'ev et 
al., 1979). Recent studies have suggested that the pool of un- 
polymerized ~/~-tubulin dimer can directly regulate the sta- 
bility of/3-tubulin mRNA (Pachter et al., 1987). This mech- 
anism allows the cell to set/3-tubulin mRNA levels and 
therefore monomer levels according to the cellular demand 
for incorporation of  monomer into microtubules.  While this 
might be taken to suggest that cellular microtubule levels are 
not set by tubulin gene expression,  the recent work of Katz 
et al. (1990) suggests otherwise. Transfection studies in yeast 
suggest  that  /3-tubulin gene  expression  may  determine 
microtubule levels  and that c~-tubulin gene expression  is 
feedback-reg~ted in response to that of/3-tubulin. 
Intermediate filament gene expression appears to be set in 
mammalian cells and not subject  to  feedback-regulation. 
Forced expression of a number of intermediate filament pro- 
reins both in cell culture and in transgenic mice has tidied 
to elicit any feedback-regulatory  response from the endoge- 
nous intermediate filament genes (Monteiro et al.,  1990). 
These results  suggest that intermediate filament levels are 
largely controlled by programmed gene expression indepen- 
dent of cytoplasmic levels of the protein. 
Microfilaments,  like  microtubules,  may be  subject to 
feedback-regulation.  It has been suggested that the micro- 
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synthesis (Schulze et al.,  1989).  Introduction of phalloidin 
into mouse embryo fibroblasts resulted in an increase in 
polymerized cytoskeletal-associated actin,  a  decrease  in 
monomeric actin and also elicited an increase in both actin 
protein synthesis and mRNA levels suggesting that actin is 
subject to feedback-regulation (Serpinskaya et al., 1990). In- 
troduction of a mutated human/3-actin gene (/~sm) into hu- 
man fibroblasts resulted in a decrease in endogenous fl- and 
7-actin protein synthesis such that the net level of total actin 
synthesis remained unchanged (Leavitt et al.,  1987a),  sup- 
porting the existence of an actin feedback-regulatory mecha- 
nism. However,  studies of actin mRNA levels in these cells 
were inconclusive since it was not possible to discriminate 
between  the  transfected  and  endogenous  human  genes 
(Leavitt et al., 1987a). Similar transfections of human/~- and 
7-actin genes into human fibroblasts have been shown to al- 
ter the ratio of/~- to 7-actin protein in a manner dependent 
on the introduced gene (Ng et al., 1988). However, complete 
analysis of actin expression in these cells was not possible 
since the transfected actin gene could not be distinguished 
from the endogenous human genes.  Thus,  while protein 
analysis indicates that actin synthesis may be  subject  to 
feedback-regulation it is unknown if actin mRNA levels are 
feedback-regulated and  also  whether  8-  and  7-actin  are 
equivalent in both their ability to generate and respond to 
feedback-regulatory stimuli.  In  the  accompanying paper 
(Scbevzov  et al., 1992),  it is shown that transfection of the 
/~- and 7-actin genes impacts differently on myoblast cytoar- 
chitecture. Is it possible that feedback-regulation contributes 
to this difference between/3- and 7-actin? For example, is 
there more actin in large cells (/~-actin transfectants) and less 
in small cells (7-actin transfectants) and therefore does the 
size of these cells reflect the impact of expression of  the actin 
genes on actin feedback-regulation? 
We have investigated the ability of  the two human nonmus- 
cle actin genes,/$ and 7, to elicit a feedback-regulatory re- 
sponse  upon  transfection into  mouse  C2  myoblasts.  Al- 
though the human and mouse isoforms are identical at the 
protein sequence level, differences between the mRNAs have 
allowed us to discriminate between transcripts from the en- 
dogenous and exogenous genes. We find that actin gene ex- 
pression is indeed subject to a form of feedback-regulation. 
However, we observe that the nature of this regulation is de- 
termined by the type of actin encoded by the transfected gene 
and is dependent upon microfilament organization. 
Materials and Methods 
Cell Culture 
Mouse C2 myoblasts isolated in the laboratory of Dr. D. Yaffe (Weizmann 
Institute, Israel) and subcloned in the laboratory of Dr. H. Blau (Stanford 
University, Stanford, CA) were grown in DMEM (Gibco Laboratories, 
Grand Island, NY) supplemented with 20% FCS (Commonwealth Serum 
Labs,  Melbourne,  Australia)  and  0.5%  chicken  embryo extract  (Flow 
Laboratories Australasia Pty. Ltd., North Ryde).  The transfection and se- 
lection of cells carrying the human ~vt-,/~sm-, ~m-, and "t-actin plasmids 
together with pSV2neo was described (Schevzov et al., 1992). Control cells 
were generated by transfection with pUC-18 plus pSV2neo. Cells were har- 
vested at 30-40%  confluence and the cultures did not contain detectable 
myotubes.  In  some  experiments,  the  cells  were  exposed to  the  actin 
depolymerizing drug,  Cytochalasin  D.  Cells  at  40%  confluence were 
treated with Cytochalasin D (Sigma Chemical Co., St. Louis, MO) at 2.5 
~g/ml (from a stock at 2 mg/ml in DMSO) for 5 h and parallel control cul- 
tures were treated with the corresponding amount of DMSO alone. 
RNA Isolation and Analysis 
Total cellular RNA was isolated from the cells by the method of Chomczyn- 
ski and Secchi (1989). RNA was size-fractionated  by formaldehyde  gel r 
trophoresis and transferred to nylon membranes as described (Gunning et 
al., 1990).  DNA probes were radiolabeled to 109 dpm#tg by the random 
priming method (Feinberg and Vogelstein, 1983) and hybridized to RNA 
blots at 106 dpm/ml in a solution containing 4x  SSC (lx  SSC is 0.15 M 
NaCI, 0.015 M sodium citrate), 50 mM NaH2PO4, pH 7.0, 5x Denhardt's 
solution (Denhardt, 1966),  and 10%  (wt/vol) dextran sulfate at 65~  for 
16 h. After hybridization the blots were washed in 0.5x  SSC, 0.1% SDS 
at 65~  except for the total actin probe which was washed at 50~  Mem- 
branes were exposed to Kodak XAR film for 1-3 d. To verify that equivalent 
amounts of RNA were transferred, the RNA blots were hybridized to an 18S 
rRNA-specific oligonucleotide probe under conditions of probe excess and 
washed in 4x SSC, 0.1% SDS at 550C. Levels of mRNAs were quantitated 
by densitometry as described (Gunning et al.,  1990). 
DNA Probes 
The  human flwt-, ~sm-,  and  ~trn-actin rnRNAs were detected using a 
human-specific /3-actin-specific  3'  untranslated  region  (3~'TR) 1 probe, 
pHF/g~-3'UT-HH,  as described (Ng et al.,  1985).  The human noumuscle 
~/-actin mRNA was detected using a human-specific  3!-actin-specific 3'UTR 
probe, pHF-IA-3'UT-HX  (Erba et al.,  1986).  The level of human/~- and 
~/-actin mRNA was measured relative to that in myoblasts cultured from 
adult human skeletal muscle as described (Gunning et al., 1987). The mouse 
~-actin mRNA was detected using a mouse-specific/~-actin-specific  DHA 
fragment containing bp 278-480 of the mouse ~-actin YUTR (M~-3'UT- 
202).  The mouse ~-actin fragment was generated by PCR amplification 
from mouse genomic DNA using appropriate oligonucleotides as described 
(Gunning et al.,  1990).  The resulting fragment was cloned between the 
BamHI and SmaI sites of pGEM-3. The mouse ~,-actin mRNA was mea- 
sured using a mouse-specific  7-actin-specific DNA fragment containing bp 
199-465 of the mouse -r-actin 3'UTR (MT-YUT-HA). The mouse ~,-actin 
probe was isolated as a HpaI-AvaII DNA fragment from a mouse cDNA 
supplied by Dr. D. Leader (University of Glasgow,  Scotland) and was sub- 
cloned into the Sinai site of pGEM-3. Total actin mRNA levels were mea- 
sured directly using a chicken/3-actin coding region probe under low strin- 
gency conditions (Cleveland et al.,  1980). 
Actin Protein Analysis 
Total  protein from cells at 30-40%  confluence was size-fractionated by 
SDS-PAGE  (Laemmli,  1970)  and  immunoblotted using  the method of 
French and Jeffrey (1986).  Actin protein was detected using a  C4 mAb 
(kindly supplied by Dr. J.  Lessard, Children's Hospital Research Founda- 
tion, Cincinatti, OH; Lessard, 1988) which reacts with all actin isoforms. 
Tubuiin  protein was detected using  an  t~-tubuiin  monoclonel antibody 
(Product No. T-9026;  Sigma Chemical Co., St. Louis, MO). The Western 
blots were scanned using a Molecular Dynamics Model 300 series comput- 
ing densitometer which allowed volumetric determinations (3 dimensional 
integrations). The levels of actin and t~-tubuiin protein were expressed as 
a percentage of that detected in control cells which was set at 100%. Identi- 
cal gels were run concurrently and  stained with Coomussie blue.  The 
Coomassie staining and the level of t~-tubuiin for each clone was used to 
correct any differences in the total actin levels that were due to unequal 
loading. 
Results 
7-Actin Gene Elicits a Feedback-Regulatory Response 
Mouse C2 myoblasts were transfected with the human 7-actin 
gene and all highly expressing cloned cells as determined by 
Northern  blot analysis,  were analyzed  in detail  (Table I). 
Cells were harvested for RNA and protein at 30% confluence 
1. Abbreviation used in this paper:  UTR, untranslated region. 
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Human actin  Total actin 
Gene  Clone  mRNA level*  protein levels~ 
pUC-18  100 
7  7~s-A2  0.55  107 
7  75s-B1  0.59  111 
7  733-B5  1.02  98 
7  758-B2  1.49  103 
7  733-B1  2.52  84 
Bwt  Bwt-25  0.10  102 
Bwt  Bwt-12  0.16  96 
Bwt  Bwt-13  0.38  179 
Bwt  Bwt-11  0.61  233 
Bsm  /3sm-62  0.45  78 
Bsm  Bsm-72  0.69  61 
Bsm  Bsm-22  1.73  89 
Btm  Btm-45  O. 12  132 
Btm  /3tm-22  O. 17  99 
Btm  13tm-43  0.36  102 
Btm  /~tm-33  0.77  85 
* Values are expressed relative to the level found in human myoblasts  which 
was set at 1. 
~: Values are expressed as a percentage of that found in control cells (trans- 
fected with plasmid pUC-18) which was set at 100%. 
shown). Increasing expression of the human 7-actin mRNA 
was associated with an altered proportion of B- to 7-actin 
protein  such  that  in  the  highest  expressing  clone,  "Y3a-B1, 
the/~/3' ratio was 0.3 compared to 2.0 in control cells (Schev- 
zov et al.,  1992). We conclude that expression of the human 
7-actin gene alters the relative levels of  B- and 7-actin protein 
in favour of 7-actin. Since the total actin protein level is es- 
sentially unchanged (Table I), this  suggests that the human 
7-actin gene  elicited  a  feedback-regulatory response  from 
the mouse actin genes. 
The impact of human 7-actin expression on the levels of 
mouse B- and 7- actin mRNAs is shown in Fig. 2. There was 
a progressive decrease in the level of the mouse B- and 7-ac- 
to ensure that cells were in logarithmic growth. Fig. 1 shows 
that increasing levels of  the human 7-actin mRNA had no im- 
pact on the  total  level  of actin protein.  The Western  blot 
shown in Fig.  1 was reacted with an et-tubulin antibody in 
parallel with the actin antibody to confirm equal transfer of 
samples to the nitrocellulose.  A gel run in parallel with this 
Western blot was stained with Coomassie blue and also used 
to  confirm  equal  loading  of samples.  In  lane  4  the  actin 
level  is decreased,  however,  both  the Coomassie blue and 
o~-tubulin  were also decreased  from the control and when 
this was taken into account the actin level was comparable 
to the other clones and the control (Table I).  Additionally, 
the  Coomassie-stained  gel  supported  the  results  since  the 
42-kD actin band was essentially identical in all samples (not 
Figure 1. Total actin protein levels in human 7-actin transfectants. 
The levels of actin and c~-tubulin protein in human 7-actin transfec- 
tant cells.  10 #g of total protein from five 7-actin transfectants  and 
control cells  (transfected  with  the  plasmid  pUC-18),  all  at  low 
confluence, was size fractionated by electrophoresis on a denatur- 
ing polyacrylamide gel.  The protein was transferred  to nitrocellu- 
lose and immunostained with antibodies  to total actin (C4) and 
c~-tubulin. The level of a-tubulin was used to normalize the actin 
levels for loading.  Loading: control (lane 1), 733-B1 (lane 2), 75s- 
B2 (lane 3), 75s-A2 (lane 4), 'Y33-B5 (lane 5), and 75s-B1 (lane 6). 
Figure 2.  Actin gene expression  in human 7-actin gene transfec- 
tants.  Total RNA was isolated  from five 7-actin transfectant  clonal 
lines  with different  levels of expression  of the human gene.  The 
RNA  was  size  fractionated  by  electrophoresis  on  denaturing 
agarose gels and transferred  to nylon membranes as described in 
Materials  and Methods.  The filters were hybridized with mouse- 
specific B- and 7-actin probes and a chicken B-actin coding region 
probe, used to detect total actin levels, then washed and autoradio- 
graphed as described in Materials  and Methods.  RNA from C2 
pUC-18 transfectants  was used as the control. To correct for loading 
discrepancies,  the filters were subsequently hybridized with a probe 
specific for 18S ribosomal RNA. 3 #g of RNA was loaded for each 
sample.  (A) Lane 1, 3,33-B1; lane 2, 3,ss-B2; lane 3, 75s-A2; lane 4, 
733-B5; lane 5, 758-B1; lane 6, control (pUC-18  transfectan0.  (B 
and C) Lane 1, control; lane 2, 3,33-B1; lane 3, 75a-B2; lane 4, 733- 
B5; lane 5, 75s-A2; lane 6, 75s-B1. 
Lloyd et al. Feedback  Regulation of Actin Gene  Expression  789 A 
o< 
Human  7  -actin  mRNA  level 
B 
I;,Q - 
>->r 
~ 
_~  6o- 
o  '~  4o- 
E  E  :'o- 
o 
I  2 
Human Y  -actin  mRNA  level 
c 
li 
"6< 
Human  Y  -actin  mRNA  level 
Figure 3. Actin mRNA levels 
in human "y-actin gene trans- 
fectants. Endogenous/3 (A), 3, 
(B),  and  total  (C)  actin 
mRNA levels were measured 
in  a  number  of clones  with 
different levels of expression 
of  the transfected human gene. 
Panels were also probed  for 
18S ribosomal RNA and cor- 
rected for loading discrepan- 
cies.  The values for each of 
the  mRNA levels were  ex- 
pressed  as  a  percentage  of 
those  found in  control  cells 
(those  transfected  with  the 
plasmid pUC-18) which were 
set at  100%. The expression 
values for the transfected gene 
are shown relative to that ob- 
served in a human myoblast 
RNA sample. Linear or loga- 
rithmic  regression  analysis 
was  performed  on  the  data 
points and the resulting line is 
shown on each graph. 
tin  mRNAs  with  increasing  expression of human  y-actin 
gene. The comparison of the highest expressing clone, 3,33- 
B1, and the control, pUC-18 transfectants, for the mRNA 
levels of mouse B-actin (A, lanes 1 and 6, respectively) and 
mouse y-actin (B, lanes 2 and 1, respectively) highlight the 
down-regulation of the mouse actin mRNA levels. The total 
actin mRNA levels in the ~-actin gene transfectants appeared 
slightly decreased compared to control cells (Fig. 2 C, lanes 
1 and 2).  The actin mRNA levels of the transfectants are 
depicted graphically in Fig. 3. Regression analysis was per- 
formed on the data points to determine if significant relation- 
ships existed between the level of expression of the trans- 
fected gene and that of the endogenous genes or that of the 
sum of the actin genes. The curves of best fit, either linear 
or logarithmic, are shown. Linear relationships were found 
to exist between the level of human 3,-actin gene expression 
and total actin (r =  0.87, P  <  0.025) and mouse 3,-actin (r 
=  0.98, P <  0.005) gene expression and a logarithmic rela- 
tionship existed between human y-actin and mouse B-actin 
(r =  0.91, P < 0.025) gene expression. Therefore, increasing 
human 3,-actin gene expression affected the levels of mouse 
/3-, mouse -~-, and total actin expression progressively such 
that mouse/3- and ,g-actin mRNA levels decreased markedly 
to compensate for human ,y-actin gene expression resulting 
in a slight decrease in total actin mRNA levels. Subsequent 
analysis of the highest expressing clone in independent ex- 
periments yielded similar results to that depicted in Fig.  3 
(Table II). The decrease measured in the mouse/3- and ~/-ac- 
tin mRNA levels was statistically significant (Table II). The 
total actin mRNA level in the highest expressing clone, how- 
ever, was not found to be significantly different to the control 
level. This result is due to the presence of one determination 
Table II. Actin Expression Levels in the Highest Expressing 
Clones of the Actin Transfectants 
Gene  Clone  M~  ME  Total actin 
~33-B1  29  •  13"  27  •  12"  93  •  32 
~.,-11  108  •  23~  182  •  34"~  238  •  31" 
~sm  ~sm-22  28  •  10"~  38  •  10"~  112  •  19 
Values are expressed as a percentage of that found in control cells (transfected 
with plasmid pUC-18) which was set at 100%. The results are the mean and 
standard deviations of three to seven independent determinations.  The values 
were compared using the t test to determine whether they were significantly 
different from the control levels (* P < 0.05) or whether the -y- and/3-actin lev- 
els were significantly different from each other  ($ P <  0.05). 
(of 138 %) which was substantially higher than the other four 
determinations made  on RNA  from this  clone.  This one 
value increased the average mRNA level and the standard de- 
viation. At this stage it cannot be concluded as to whether 
there is no change in the total actin mRNA level in 3,-actin 
transfectants or a slight decrease, although the latter is more 
likely. 
Addition of the mRNA levels of each of the actin species, 
mouse ~-  and  "y-actin and human -t-actin,  present in the 
q/-actin  transfectants suggested that the total actin mRNA 
pool was slightly decreased in these cells. The calculation for 
each transfectant clone was carried out in the following man- 
ner. Firstly, the levels of mouse/~- and -y-actin mRNA in the 
~/-actin  transfectants were determined relative to those in 
control cells and expressed in arbitrary units. The units were 
set  such that in control cells the mRNA  levels of mouse 
/3- and 3,-actin were 2 and 1, respectively, since these cells 
have a/3/3' of 2  (Erba et al.,  1988).  Secondly, the human 
~/-actin mRNA contribution was determined using the fol- 
lowing method. The level of human ~-actin in the transfec- 
tants was  determined relative to that in a human myoblast 
standard. Next, the actin mRNA level in the human myoblast 
standard was compared to that in the mouse C2 control ceils 
and found to be 70% (data not shown). The level of human 
-y-actin  mRNA  in the transfectants was then converted to 
mouse equivalents by multiplication by the factor 0.7. The 
levels of all actin mRNA, human and mouse, in the transfec- 
tants were added and then divided by the total actin mRNA 
level found in control cells to obtain the calculated percent- 
age of total actin compared to the control level (Table III). 
The calculated percentages of total actin mRNA were com- 
pared with direct measurements of the total actin mRNA lev- 
els which were achieved by using  an actin coding region 
probe at reduced stringency (Figs. 2  C and 3).  The values 
for  total  actin  mRNA  levels  determined  by  these  two 
methods are similar (Table III). The down-regulation of the 
mouse actin mRNAs compensated for the increasing human 
3~-actin mRNA levels such that the total actin mRNA level 
in the cells decreased only slightly (Fig. 3, Table III). 
We conclude that expression of the human "y-actin gene is 
capable of eliciting a feedback-regulatory response from the 
myoblast actin genes. Total actin levels in the transfectants 
were similar to those for control cells at the protein level 
(measured by immunoblotting of Westerns and Coomassie 
blue staining of protein gels) and slightly lower than control 
cells at the mRNA level (directly measured with a total actin- 
specific probe and indirectly by addition of the levels of all 
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Calculated percentage  Measured percentage 
Clone  MB*  MT*  H~  HT*  Total  of total actinw  of total actinw 
pUC-18  2.0  1.0  -  -  3.0  100  100 
3'ss-B1  1.0  0.7  -  0.4  2.1  70  83 
3',-B5  0.9  0.5  -  0.7  2.1  70  87 
3'58-B2  0.7  0.5  -  1.0  2.2  73  84 
'y33-B1  0.6  0.2  -  1.8  2.6  87  75 
/3wt-25  2.5  0.9  0.1  -  3.5  117  132 
/3wt-12  3.3  1.2  0.2  -  4.7  157  122 
/3wt-13  3.6  0.9  0.5  -  5.0  167  156 
Bwt-11  3.6  0.9  0.9  -  5.4  180  241 
/3sm-62  2.0  0.6  0.6  -  3.2  107  71 
Bsm-72  1.3  0.4  1.0  -  2.7  90  80 
/~sm-22  1.1  0.2  2.4  -  3.7  123  93 
/~tm-45  2.0  1.1  0.2  -  3.3  110  114 
/~tm-22  2.1  0.9  0.2  -  3.2  107  127 
Btm-43  1.9  0.9  0.5  -  3.3  110  122 
Btm-33  1.9  1.1  1.1  -  4.1  137  137 
* Values are expressed as arbitrary units relative to the level found in control cells where/3- and ),-actin levels were set to 2 and 1, respectively. 
* Values were initially  determined  relative to the level found in human myoblasts  (expressed  as arbitrary units as for *) and then adjusted to the levels found in 
mouse control cells. This was achieved  by multiplication  of the relative human level by 0.7 since human myoblasts  contain 70% the level of actin as in mouse 
C2 myoblasts  (data not shown). 
w  Values are expressed as a percentage of that found in control cells (transfected  with plasmid pUC-18) which was set at 100%. 
M and H refer to mouse and human, respectively. 
the actin mRNAs).  The endogenous/3- and 7-actin mRNA 
levels decreased in a logarithmic and linear fashion, respec- 
tively, with increasing human 3,-actin gene expression and 
this change in the relative expression of/3- to ~/-actin was 
reflected in the protein/3/~ ratio measured by IEF determi- 
nations (Schevzov et al.,  1992). 
/3-Actin Gene Increases Actin Pool Size 
Transfection of the human/3wt-actin gene into C2 cells led 
to an increase in the total actin protein pool size of up to 
230% in the highest expressing clone (Table I). An increase 
in the actin pool size was also observed by visualization of 
the 42-kD actin band using Coomassie staining of the gel 
loaded with total protein from  the/3wt-actin transfectants 
(data not shown).  The increase in pool size was paralleled 
by an increase in the ratio of/3- to 7-actin protein, up to 2.8 
in the highest expressing clone (Schevzov et al., 1992). This 
suggests that, unlike the 7-actin gene, expression of the/5~vt- 
actin  gene  does  not  elicit a  feedback-regulatory response 
from the endogenous mouse actin genes. 
To test directly that there had been no feedback-regulatory 
response from the mouse actin genes in the/3wt-actin trans- 
fectants, the mouse/3- and 3,-actin mRNA levels were mea- 
sured. Fig. 4 shows that the mouse 3,-actin mRNA level was 
unchanged;  however,  the  mouse  /3-actin mRNA  level  in- 
creased  in  parallel  with  expression  of the  human  gene. 
Regression analysis was performed on the data points and a 
linear relationship was  found to exist between the mRNA 
levels of human/3wt-actin and total actin (r =  0.89, P <  0.01) 
and mouse/3-actin (r =  0.85, P  <  0.025) suggesting that ex- 
pression of the human Bwt-actin gene affected endogenous 
/3-actin  expression.  However,  regression  analysis  of  the 
mouse -y-actin results indicated that there was no relationship 
with  human  /5~vt-actin  gene  expression,  but  rather  that 
mouse -t-actin mRNA levels were constant (r =  0.51, P  > 
0.1). The levels of the mouse actin mRNAs in the highest ex- 
pressing clone were analyzed in subsequent independent ex- 
periments  and  similar  results  were  obtained  (Table  ID. 
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scribed in the legend to Fig. 3. 
Linear regression of the data 
points for 7-actin (B) revealed 
that  the  line  which  fits  the 
points does not have a  slope 
significantly  different  from 
zero,  indicating  that  mouse 
3,-actin  levels  were  constant 
for  varying  Bwt-actin  actin 
levels. 
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mouse and human actin mRNA levels were added and as ex- 
pected, the total actin mRNA pool size increased in parallel 
with the total protein pool (Tables I and III). Independent de- 
termination of total actin mRNA levels using a total actin- 
specific probe yielded similar results (Fig. 4 and Table III). 
We conclude that increasing expression of the human flwt- 
actin gene induces a response from the mouse/~-actin gene 
which promotes an increase in both actin mRNA (Table III) 
and protein (Table I) pool size. This is in contrast to the re- 
sponse to expression of the human 3,-actin gene indicating 
that C2 cells can discriminate between the nonmuscle actin 
genes at least with respect to feedback-regulation. In addi- 
tion, human/~wt-actin gene expression invokes statistically 
significant different responses  from the endogenous actin 
genes (Table II). Beta-actin expression increases; whereas 
7-actin  expression  remains  constant.  This  also  indicates 
feedback-regulatory differences between the two nonmuscle 
actin genes. 
flsm-Actin Gene Elicits a Feedback-Regulatory 
Response 
We have previously observed that the highest expressing 
#wt-actin transfectants show a  substantial increase in cell 
volume  (over  twofold),  whereas  the  -y-actin transfectants 
have a reduced cell volume (Schevzov  et al.,  1992).  In the 
case of flwt-actin gene transfectants, there is a clear correla- 
tion between the increase in actin pool size and cell morphol- 
ogy. In the same experiment, we observed that transfection 
ofa/3-actin gene (/3sm) carrying a single point mutation pro- 
duced a morphological phenotype similar to that of -/-actin 
(Schevzov et ai.,  1992).  This suggested to us that the mor- 
phological impact of these different genes was dependent on 
the encoded protein. By analogy, we would predict that the 
/3wt- and  flsm-actin  genes  may have  different feedback- 
regulatory impact on the endogenous actin genes. 
Analysis of C2 cells transfected with the/3sm-actin gene 
revealed that the total actin protein pool was slightly de- 
creased (Table I). Coomassie staining of a gel loaded with 
total protein from the transfectants revealed that there was 
a progressive replacement of the 42-kD actin band by the 44- 
kD mutant actin band with increasing expression of  the flsm- 
actin gene (data not shown). Direct determination of the to- 
tal actin mRNA pool using a total actin-specific probe and 
addition of the mouse and human actin mRNAs both showed 
that total actin mRNA levels were essentially unchanged 
(Fig. 5 and Table UI). Regression analysis was performed on 
the data points and demonstrated that there was no relation- 
ship between ~sm-actin and total actin mRNA expression; 
instead total actin mRNA levels  were constant (r  =  0.04, 
P > 0.1). Thus, expression of the/3sm-actin gene invoked a 
feedback-regulatory response such that endogenous actin ex- 
pression decreased to compensate for the human actin ex- 
pression in order to maintain a relatively  constant total actin 
protein and mRNA pool size. 
Increasing ~sm-actin gene expression is compensated by 
a progressive decrease in the levels  of both mouse/3- and 
"y-actin mRNAs (Fig. 5). Regression analysis was performed 
on the data points and a linear relationship was found to exist 
between the level of human flsm-actin and mouse/3-actin 
(r  =  0.88, P  <  0.05) mRNA expression and a logarithmic 
relationship was found between/~sm-actin and 3,-actin (r = 
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Figure 5. Actin  mRNA levels 
in  human  flsm-actin gene 
transfectants. Endogenous /3 
(A), 3' (B), and total (C) actin 
mRNA levels were measured 
in a  number of clones with 
different levels of expression 
of  the transfected  human gene. 
Determination of mRNA lev- 
els was as described in the leg- 
end to Fig. 3. Linear regres- 
sion of  the data points for total 
actin (C) revealed  that the line 
which fits the points does not 
have a slope significantly  dif- 
ferent  from  zero, indicating 
that  total  actin  levels were 
constant  for  varying  Bsm- 
actin actin levels. 
0.98, P < 0.025) mRNA expression indicating that/~sm-actin 
gene expression resulted in altered endogenous actin expres- 
sion. In addition, it is apparent that mouse ~-actin mRNA 
is down-regulated to a greater extent than/3-actin mRNA in 
all transfectants (Fig. 5). Independent experiments with the 
highest expressing clone also exhibited a statistically signifi- 
cant difference in the response of the mouse/3- and ~-actin 
genes (Table II). 
The feedback-regulatory response elicited by the introduc- 
tion of  the/3sm-actin gene into C2 myoblasts contrasted with 
that elicited by the/~wt-actin gene. Expression of the/~sm- 
actin gene resulted in a decrease in both endogenous/~- and 
~/-actin mRNA levels (Fig. 5) while the total actin pool, both 
mRNA and protein, was relatively constant (Tables I and III, 
Fig. 5). In contrast,/~wt-actin gene expression induced ex- 
pression of the endogenous/3-actin gene while not signifi- 
cantly altering 7-actin gene expression resulting in an in- 
creased total actin pool size (Tables I and III, Fig. 4). The 
different regulatory responses elicited by the introduction of 
/~wt- and/~sm-actin genes into C2 myoblasts suggests that it 
is the nature of the protein encoded by the transfectant gene 
that  determines  the  feedback-regulatory response  of the 
mouse actin genes. 
Promoter competition is eliminated as a possible mecha- 
nism for the feedback-regulatory responses elicited because 
the/5~wt  - and/3sm-actin genes have identical promoters. To 
further rule out promoter competition as a feedback-regula- 
tory mechanism, analysis of/~tm-actin gene transfectants 
was performed. This form of the/3-actin gene has three point 
mutations and results in an unstable protein product (Lin et 
al.,  1985).  The/3tm-actin gene transfectants were found to 
exhibit normal C2 cell morphology and had a normal/3 to 
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gene expression resulted in no change in total actin protein 
levels  (Table I), contrasting with the increase observed in 
Bwt-actin transfectants. The actin mRNA levels were then 
examined  in  these  transfectants (Fig.  6).  There  was  no 
significant change in either mouse fl- or ~t-actin levels in re- 
sponse to increasing levels of fltm-actin gene expression. 
Regression  analysis  was  performed  on  this  data  and 
confirmed these  findings  (for  mouse  v-actin  r  =  0.24, 
P > 0.I and for mouse fl-actin r =  0.70, P < 0.05). However, 
total actin mRNA levels increased in a linear fashion with 
increasing fltm-actin gene expression (r =  0.85, P < 0.025). 
This increase was confirmed by calculation of  the percentage 
of total actin mRNA from the levels of mouse fl- and 3,-actin 
and human fltm-actin mRNA (Table HI). Therefore, expres- 
sion of the fltm-actin gene did not affect expression of the 
mouse actin genes but simply added to the total actin mRNA 
pool. However, the actin protein pool was not altered and no 
Btm-actin gene protein product was detectable (Schevzov 
et el., 1992). The fltm-actin gene results are also not compat- 
ible with a promoter competition mechanism operating for 
actin feedback-regulation since expression of an additional 
fl-actin promoter did not decrease endogenous fl- or "y-actin 
expression. Additionally, the difference in the responses by 
the mouse fl-actin gene to expression of the Bwt- and fltm- 
actin genes strongly suggests that the form of the protein en- 
coded  by  the  transfectant gene  influences the  feedback- 
regulatory responses of the mouse actin genes. 
Actin Cytoskeletal Organization Is Involved in Actin 
Feedback-Regulation 
The feedback-regulatory responses of the mouse actin genes 
may have been related to the change in cell morphology 
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resulting from expression of the human genes. Certainly, the 
observation that the nature of the encoded protein dictates 
the mouse actin feedback-regulatory response is most easily 
reconciled with a mechanism that relates actin function to 
gene  regulation.  For  example,  it may be  that  feedback- 
regulation of actin mRNA levels is mediated in some manner 
by the morphological demands of the cell such as tension 
maintained by actin cables in the cell.  Assuming this to 
be the case, alterations in the organization of the actin cy- 
toskeleton may lead to changes in actin gene expression. 
Therefore, we tested whether the down-regnlation of mouse 
fl- and 3,-actin rnRNA levels in the "y- and flsm-actin transfec- 
tants was determined by the actin organization in these cells. 
The actin cytoskeleton of transfectant cells was disrupted 
by exposing the cells to Cytochalasin D. Treatment of cells 
with Cytochalasin D has been found to severely disrupt net- 
work organization, increase the number of actin filament 
ends, and lead to the formation of filamentous aggregates 
composed mainly of actin filaments (Schliwa, 1982).  After 
a 5-h treatment with Cytochalasin D, actin stress fibers, as 
evaluated by immunofluorescent staining with an actin anti- 
body, were essentially eliminated (Fig. 7). After disorgani- 
zation of the control cell actin cytoskeleton a 1.5- and 2-fold 
increase  was  observed  in  fl-  and  3,-actin  mRNA  levels, 
respectively (Fig.  8,  Table  IV).  Similar increases in actin 
mRNA levels (Sympson and Geoghegan, 1990) and protein 
synthesis (Tarmenbaum,  1986) after Cytochalasin D  treat- 
ment have been described. Interestingly, the flsm- and 3,-actin 
gene transfectant cells also exhibited an increase in the mouse 
actin mRNA levels.  Mouse ~-actin mRNA levels increased 
twofold while ~/-actin mRNA levels increased sixfold (Fig. 
8, Table IV). In particular, while the mouse fl-aetin mRNA 
level increased after Cytochalasin D treatment, it did not re- 
turn to control cell values (Fig. 8). The mouse 3,-actin mRNA 
level, however, increased to a level that was not significantly 
different to that seen in the treated control cells (Fig. 8). 
Thus, the compensating down-regulation of mouse ~-actin 
expression in the flsm- and "y-actin transfectants was abol- 
ished after disruption of the actin cytoskeleton. This sug- 
gests that the organization of the actin cytoskeleton is in- 
volved in the feedback-regulation of 3,-actin gene expression 
in the transfectants. 
The down-regulation of mouse fl-actin in the -y- and flsm- 
actin transfectants was relieved partially after disorganiza- 
tion of the cytoskeleton. Interestingly, the fold increase in 
mouse B-actin mRNA levels after Cytochalasin D treatment 
was statistically equivalent in all transfectant cell lines tested 
(Table IV). This suggests that there was no specific relief of 
B-actin  mRNA down-regulation in the ~-  and flsm-actin 
Table IV. Increase in Endogenous Actin Expression 
after Cytochalasin D Treatment 
Clone  M'y  Mfl 
pUC-18  196  +  36  147  +  39 
733-B1  550  +  177"  220  +  45 
fl~-22  623  +  173"  182  5:36 
The values are expressed as a percentage of the actin expression level in the 
untreated cells, The results are the mean and standard deviations of three in- 
dependent experiments. 
* This symbol indicates that the values ate significantly different (P < 0.05 us- 
ing the t test) from the increase measured for the pUC-18 cells. 
Lloyd et el, Feedback Regulation of  Actin Gene Expression  793 Figure 7. Depolymerization of actin filaments after Cytochalasin D treatment. Control (transfected with the plasmid pUC-18) and clonal 
derived cells were treated with Cytochalasin  D at 2.5 #g/ml (stock 2 mg/ml in DMSO) for 5 h or with an appropriate amount of DMSO 
(samples without Cytochalasin  D treatment).  The cells were grown on collagen-coated glass slides, treated with Cytochalasin  D or with 
DMSO, and then fixed and permeabilized  using  1% formaldehyde followed by methanol.  Visualization of actin filaments was achieved 
by indirect immunofluorescence staining of  the cells with a general actin antibody (C4) followed by fluorescein-conjugated goat anti-mouse 
IgG. Photos (A and B) control cells,  (C and D) "y33-B1 and (E and F)/~sm-22. Cells without Cytochalasin  D treatment  (A, C, and E) 
and cells with Cytochalasin  D treatment  (B, D, and F). Bar,  10 #m. 
transfectants. Instead fl-actin expression was stimulated after 
disorganization of the actin cytoskeleton in all transfectants 
perhaps resulting from activation of an enhancer region in 
the fl-actin promoter. The difference in the magnitude of the 
increase in fl- versus -r-actin mRNA levels in the transfec- 
tants also indicates that the two actin isoforms are regulated 
differently. In particular, the results suggest that the mecha- 
nism responsible for the down-regulation of fl-actin in ,y- and 
flsm-actin transfectant cells may be distinct from that gov- 
erning 7-actin. 
Discussion 
Actin Gene Expression Is Subject to 
Feedback Regulation 
Our data shows that the size of both the actin protein and 
mRNA pools is not absolutely fixed in C2 myoblasts. Previ- 
ous studies in human fibroblastic cell lines have suggested 
that transfection of the four genes used in this study does not 
alter total actin protein synthesis (Leavitt et al.,  1987a; Ng 
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lasin D treatment on the actin 
200  mRNA  levels  in  actin  gene 
transfectants.  Endogenous  T 
([])  and  B (I)  actin  mRNA 
~60  levels were measured  in hu- 
man actin gene transfectants 
<  ~20  with and without Cytochalasin 
z  D  treatment.  Pooled  clones  a: 
E  were used for the control ceils 
60  (pUC-18 transfectants) and the 
clones with the highest levels 
40  of  expression of  the transfected 
genes were used from each ac- 
tin gene transfection: human 
0 
-CytD *CytD -CytD  +CytD -CytD  +CytD  T-actin  transfectant,  T33-B1 
control  Y33-B1 [~srn-22  and  human  B-single mutant 
actin  transfectant,  Bsm-22. 
Cells were treated with Cytochalasin D at 2.5 #g/ml (stock 2 mg/ml 
in DMSO) for 5 h or with an appropriate amount of DMSO (sam- 
ples without Cytochalasin D treatment).  Panels were probed for 
18S ribosomal RNA and corrected for loading discrepancies. The 
values for endogenous actin mRNA levels were expressed relative 
to those detected in untreated control cells. The error bars represent 
the standard deviations of  the means. The * denotes that the mRNA 
level after Cytochalasin  D  treatment  was  significantly different 
from that of the treated control mRNA level (t test, P < 0.05). 
et al., 1988). The difference between these experiments may 
reflect the extent of expression achieved with the Bwt-actin 
gene in these two systems. High level expression of  the trans- 
fected/~wt-actin gene was required to observe an increase in 
the myoblast actin pool size. Because Leavitt and co-workers 
could not discriminate between the transfected and endoge- 
nous Bwt-actin mRNAs, it is uncertain that they attained lev- 
els of exogenous gene expression comparable to those at 
which we observed an increased pool size (Leavitt et al., 
1987a). 
C2 myoblasts transfected with the flsm-actin gene exhibited 
differential down-regulation of the endogenous/$- and 3,-actin 
mRNA levels. In contrast, Leavitt et al. (1987a) found that 
in human fibroblasts expressing the flsm-actin gene the pro- 
tein synthesis for both endogenous t- and 3,-actin decreased 
to the same extent. Interestingly, the ~-actin mRNA level did 
not decrease in Hut-12 cells transfected with the ~sm-actin 
gene (Leavitt et al.,  1987b). The expression of endogenous 
B-actin in the human transfectants could not be determined 
since it was impossible to discriminate between the trans- 
fected and endogenous fl-actin mRNAs. However, there are 
clearly differences in T-actin expression between the fibro- 
blasts and C2 myoblasts expressing the Bsm-actin gene. This 
suggests that the actin feedback-regulation found in C2 myo- 
blasts may not be extrapolated to all other cell types. 
Feedback-regulation of actin  isoform expression in  re- 
sponse to expression of an exogenous actin gene occurs at 
the level of mRNA accumulation. The simplest mechanism 
which might account for this is promoter competition. For 
example, both the t- and T-actin genes contain serum re- 
sponse  elements  in  their  promoter  regions  (Erba  et  al., 
1988). However, the observation that expression of the Bwt-, 
flsm-, and ~tm-actin genes elicit such divergent feedback- 
regulatory  responses  is  not  compatible  with  a  promoter 
competition model. Indeed, the finding that expression of  the 
human Bwt-actin gene results in elevated mouse ~-actin ex- 
pression is totally incompatible with promoter competition. 
The autoregulatory mechanism described by Pachter et al. 
(1987) for B-tubulin involves the ot/~-tubulin dimer directly 
regulating  tubulin  mRNA  levels  such  that  the  level  of 
B-tubulin mRNA appears to be fixed. Ifa similar mechanism 
was operating for actin feedback-regulation it would be ex- 
pected that exogenous actin expression would be compen- 
sated for by a decrease in endogenous actin expression in or- 
der  to  maintain  a  constant  actin  mRNA  pool  size.  The 
elevated mouse #-actin expression in the/SXvt-actin transfec- 
tants is incompatible with a  simple actin monomer-driven 
feedback mechanism. If the level of monomer was to control 
expression of the actin genes,  one would predict that as a 
transfected gene began to be expressed, the monomer pool 
would start to rise which would then lead to reduced expres- 
sion of both the endogenous and transfected genes. In this 
way, a monomer control mechanism would essentially act to 
prevent any increase in actin monomer and polymer pools. 
Thus,  an increase in actin pool size and especially an in- 
crease in endogenous I$-actin expression should not be possi- 
ble under a simple monomer control mechanism. 
The feedback-regulation of expression of the three major 
structural polymer systems in mammalian cells appears to 
be unique for each structural element.  Cleveland and co- 
workers (Pachter et al.,  1987; Yen et al.,  1988) have found 
that the (x/3-tubulin dimer levels regulate B-tubulin mRNA 
stability. This serves to regulate/~-tubulin mRNA levels in 
accordance with the ability of the protein product to incor- 
porate into microtubules. Thus, tubulin represents a true au- 
toregulatory system in which the product directly controls 
its own synthesis. However, the autoregulation of tubulin ex- 
pression may not simply be controlled by the subunit levels 
since Katz et al.  (1990) found that expression of an extra 
tubulin  gene  in  yeast  resulted  in  an  increase  in  tubulin 
mRNA levels and a slight increase in tubulin protein levels. 
Although similar to that observed with the/3-actin transfec- 
tants, the protein levels did not parallel the mRNA levels 
contrasting with that found for the actin transfectants. The 
intermediate filament system appears to have no feedback- 
regulation of pool size such that expression of an exogenous 
gene can elevate the pool without having any impact on en- 
dogenous gene expression (Monteiro et al.,  1990).  Actin 
may therefore present us with a third mechanism in which 
actin filament organization may play a role in the feedback- 
regulation of the levels of actin mRNA.  Thus, actin gene 
expression appears to be subject to flexible feedback-regula- 
tion, and not true autoregulation, in which the actin cyto- 
skeletal organization may be a key component of the regula- 
tory mechanism. 
f3- and ,y-Actin Genes Are Functionally Different 
In this study, we have found that transfection of/3wt- and 
?-actin  genes  are  not equivalent in  their  ability  to  elicit 
feedback-regulatory responses from the mouse actin genes. 
Furthermore, the mouse actin genes respond differently to 
the same human actin gene; at least for the Bwt- and/3sm- 
actin genes.  Finally, the different responses of the mouse 
B- and ?-actin genes in both the ?- and ~sm-actin transfec- 
tants after disruption of the cytoskeleton indicates that regu- 
lation of ~- and 3,-actin  may be mediated differently. This 
suggests that the actin feedback-regulation mechanism can 
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Therefore, we have identified  a biochemical difference be- 
tween the nonmuscle actin genes. The availability of this bio- 
chemical assay now provides us with a crucial tool necessary 
to define the level at which the genes encoding actin isoforms 
are functionally different.  Experiments are presently under- 
way to determine whether the protein product of the actin 
genes, the gene sequences themselves or a combination of 
the two determine the actin feedback-regulatory response. It 
should  be  noted,  however,  that  the  differing  responses 
elicited in the/3wt-,/~sm-, and/~tm-actin  transfectants  sug- 
gest  involvement  of  the  protein  in  the  actin  feedback- 
regulatory response. 
Actin  feedback-regulation  differs  to tubulin autoregula- 
tion with respect to the regulatory responses of different 
isoforms.  Both of the mouse nonmuscle actin  isoforms  re- 
sponded to the expression of the human 7-actin gene in C2 
myoblasts demonstrating  that the levels of/~- and 3,-actin are 
not fixed  in  these cells.  In contrast,  the expression of a 
chicken class Iv"/~-tubulin gene in CHO cells precipitated a 
decrease in expression of the endogenous class IV isotype so 
that the total level of class IV isotypes remained unchanged. 
However, the class I isotype level was not affected (Sisodia 
et al.,  1990).  Expression of/3-tubulin appears to involve a 
true autoregulatory system in that the levels of specific iso- 
types are fixed. The CHO cells were able to maintain these 
fixed expression levels by reducing endogenous expression 
of the tubulin isotype corresponding to that which was trans- 
fected into the cells. In contrast, C2 myoblasts allow the lev- 
els of/~- and 3t-actin to change and so transfectant  cells with 
skewed/3/3,  ratios can be obtained. There are two possible 
explanations  for the differences between the ~-tubulin and 
actin  feedback-regulatory systems:  actin  and  tubulin  are 
regulated differently,  or C2 myoblasts and CHO cells have 
different feedback-regulatory mechanisms.  At this time, nei- 
ther possibility can be eliminated. 
Relationship of  Actin Gene Expression and 
Cell Morphology 
There is a close correlation between cell morphology and ac- 
tin gene expression in human actin gene transfectants.  The 
contrasting  effects of transfection  of the/3wt-,/3sm-,/3tm-, 
and  3,-actin  genes  on  cell  morphology and  surface area 
(Schevzov et al., 1992) closely parallel their impact on actin 
pool sizes and mouse actin gene expression.  The question 
arises as to whether actin gene regulation  reflects the mor- 
phological impact of the human gene or the morphological 
effects  observed  in  the  transfectants  result  from  altered 
mouse actin gene expression in response to human actin gene 
expression. In a multicomponent system, such as transfected 
cells,  it is almost impossible to answer such a  question. 
However, our results would support the first possibility. The 
ability of Cytochalasin D  treatment to abolish the down- 
regulation of mouse ,y-actin mRNA in the/3sin- and 3,-actin 
transfectants  emphasizes the role that the aetin cytoskeleton 
plays in the gene regulatory process. Additionally, the eleva- 
tion of mouse #-actin expression in the/~vt-aetin transfec- 
tants is hard to explain by promoter competition or other de- 
scribed feedback-regulatory  mechanism.  It may be explained 
by the morphological demands of  the/~vt-actin transfectants. 
Immediately after transfection,  high levels of Bwt-actin may 
have been expressed resulting  in an increase in/~-actin  pro- 
tein which was then incorporated into the cytoskeleton. Af- 
ter integration  of the human/~t-actin  gene, the exogenous 
gene expression may have decreased and in order to maintain 
the resultant morphology, large cells with well-defined stress 
fibers (Schevzov et al.,  1992), there was an increase in the 
endogenous #-actin gene expression. 
The role of cell morphology in the feedback-regulation  of 
cytoskeletal protein gene expression has been the subject of 
considerable  debate  (Ben-Ze'ev,  1986).  Previous  experi- 
ments by Ben-Ze'ev and co-workers have suggested that cell 
morphology can feedback-regulate the expression of genes 
involved in the maintenance  of cell cytoarchitecture (Ben- 
Ze'ev, 1986). In such studies,  changes in cell growth condi- 
tions and interactions  with extracellular  matrix components 
have been found to alter actin protein synthesis and mRNA 
levels  (Farmer  et al.,  1983;  Ben Ze'ev  and  Amsterdam, 
1986). Because such studies may involve changes in the ac- 
tivity of signal transduction pathways in the cells, it is un- 
clear if the observed actin regulation is truly due to feedback 
control via the cytoskeleton. Indeed, both actin and vinculin 
gene expression are very sensitive to growth factor stimula- 
tion (Ben-Ze'ev  et al.,  1990;  Greenberg and Ziff,  1984). 
While our experiments support the argument that actin gene 
expression can  be feedback-regulated via changes  in  the 
cytoskeleton, it is likely that other mechanisms also operate 
to regulate actin genes. 
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